First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma

C. Le Tourneau, Marie Dutreix, Célèste Lebbé et al.|British Journal of Cancer|2016

Cited by 35